glycine has been researched along with Cutaneous T-Cell Lymphoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boonstra, PS | 1 |
| Polk, A | 1 |
| Brown, N | 1 |
| Hristov, AC | 1 |
| Bailey, NG | 1 |
| Kaminski, MS | 1 |
| Phillips, T | 1 |
| Devata, S | 1 |
| Mayer, T | 1 |
| Wilcox, RA | 1 |
1 trial available for glycine and Cutaneous T-Cell Lymphoma
| Article | Year |
|---|---|
A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T-cell lymphomas.
Topics: Aged; Boron Compounds; Cell Line, Tumor; Female; GATA3 Transcription Factor; Glycine; Humans; Lympho | 2017 |